Efficacy and safety of inhaled insulin therapy [2]

Annals of Internal Medicine

Volumn 144, Issue 7, 2006, Pages 533-

  Tosiello, Lorraine ^a   Ravi, Priya ^a  

^a OVERLOOK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; PLACEBO; TROGLITAZONE;

CLINICAL TRIAL; DIABETES MELLITUS; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERINSULINEMIA; INSULIN TREATMENT; LETTER; LONG TERM CARE; PATIENT CARE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE;

ADMINISTRATION, INHALATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; RESEARCH DESIGN;

EID: 33645834073     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-144-7-200604040-00017     Document Type: Letter

References (1)

1. Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549-58.